Larimar Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Market Capitalization	412	200	179	191	329	41	183	127	87	171	700
Market Cap Growth	-	11.79%	-6.49%	-41.88%	692.51%	-77.27%	43.71%	46.12%	-49.26%	-75.54%	-
Enterprise Value	330	117	64	126	241	41	85	45	-39	-7	592
PE Ratio	-5.41	-5.41	-5.05	-3.77	-7.74	-1.79	-2.97	-2.44	-1.50	-2.31	-19.15
PB Ratio	5.04	2.44	1.61	2.97	3.67	-59.78	1.96	1.62	0.71	1.01	6.71
P/FCF Ratio	-5.94	-5.94	-6.46	-4.50	-7.78	-1.82	-3.54	-2.90	-1.65	-2.85	-24.75
P/OCF Ratio	-5.97	-5.97	-6.48	-4.54	-7.79	-1.83	-3.54	-2.90	-1.67	-2.88	-24.80
EV/EBITDA Ratio	-3.20	-3.20	-1.84	-2.50	-5.70	-1.76	-1.44	-0.87	0.68	0.10	-16.64
EV/EBIT Ratio	-3.17	-3.17	-1.82	-2.48	-5.68	-1.75	-1.43	-0.87	0.67	0.10	-16.64
EV/FCF Ratio	-3.49	-3.49	-2.33	-2.96	-5.71	-1.78	-1.65	-1.03	0.74	0.12	-20.93
Debt / Equity Ratio	0.07	0.07	0.05	0.09	0.07	-0.14	0.22	0.26	0.03	0.04	0.07
Debt / EBITDA Ratio	-0.15	-0.15	-0.15	-0.12	-0.15	0.00	-0.35	-0.39	-0.06	-0.09	-0.21
Debt / FCF Ratio	-0.16	-0.16	-0.20	-0.14	-0.15	0.00	-0.40	-0.46	-0.07	-0.11	-0.27
Quick Ratio	9.27	9.27	11.19	8.08	10.45	0.17	8.87	13.99	13.06	11.19	16.73
Current Ratio	9.49	9.49	11.28	8.16	10.89	0.81	9.12	14.39	13.23	11.37	16.98
Interest Coverage	-	-	-	-	-	-	-31.33	-314.32	-108.41	-91.17	-40.93
Return on Equity (ROE)	-38.80%	-38.80%	-42.00%	-71.60%	-47.80%	-43.30%	-78.10%	-55.10%	-42.20%	-37.80%	-54.60%
Return on Assets (ROA)	-34.30%	-34.30%	-35.90%	-59.50%	-40.70%	-29.60%	-57.60%	-48.40%	-38.60%	-34.70%	-34.40%
Return on Capital (ROIC)	-47.85%	-47.85%	-31.40%	-71.67%	-44.49%	3888.44%	-53.66%	-53.96%	-46.46%	-42.06%	-31.73%
Earnings Yield	-8.96%	-18.50%	-19.78%	-26.50%	-12.92%	-55.76%	-33.62%	-40.97%	-66.59%	-43.36%	-5.22%
FCF Yield	-8.16%	-16.83%	-15.48%	-22.21%	-12.85%	-54.92%	-28.27%	-34.52%	-60.56%	-35.11%	-4.04%
Buyback Yield / Dilution	-70.41%	-70.41%	-50.09%	-44.44%	-95.09%	-126.80%	-17.48%	-0.50%	-2.03%	-119.51%	-1572.04%
Total Shareholder Return	-70.41%	-70.41%	-50.09%	-44.44%	-95.09%	-126.80%	-17.48%	-0.50%	-2.03%	-119.51%	-1572.04%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).